• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性肾脏病患者的卒中特征与管理

Stroke features and management in patients with chronic kidney disease.

作者信息

Kamouchi Masahiro

机构信息

Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University Hospital, Fukuoka, Japan.

出版信息

Contrib Nephrol. 2013;179:92-9. doi: 10.1159/000346727. Epub 2013 May 3.

DOI:10.1159/000346727
PMID:23652452
Abstract

Chronic kidney disease (CKD) is an independent risk factor for cardiovascular diseases, including stroke. Patients with CKD are susceptible to ischemic as well as hemorrhagic stroke. The impairments in the small vessel vasculature, atherosclerotic changes of the large vessels, and coagulation abnormalities in CKD probably underlie the specific characteristics of stroke in these patients. The clinical outcomes, including the functional outcomes and short- as well as long-term mortality after stroke, are poor in patients with CKD. CKD is defined as a decreased glomerular filtration rate (GFR) and/or increased urine albumin excretion. A number of studies have shown that either or both of these two markers were significantly associated with poor functional outcomes and mortality after stroke. Recent studies have suggested that proteinuria/albuminuria is more deeply involved in the clinical outcomes than GFR. Although the mechanisms responsible for their association are currently unclear, glomerular barrier and/or filtration dysfunction are probably related to the small vessel diseases, hypercoagulability and inflammation, which may affect the clinical outcomes in CKD patients after stroke. The evidence for the most effective management of acute stroke in CKD patients is lacking, and thus, the current treatment for stroke is optimized for individual patients based on their background. Further studies are thus needed to elucidate the specific features of stroke and also the management of stroke in patients with CKD.

摘要

慢性肾脏病(CKD)是包括中风在内的心血管疾病的独立危险因素。CKD患者易发生缺血性和出血性中风。CKD患者的小血管脉管系统损伤、大血管动脉粥样硬化改变以及凝血异常可能是这些患者中风的特定特征的基础。CKD患者中风后的临床结局,包括功能结局以及短期和长期死亡率都很差。CKD的定义为肾小球滤过率(GFR)降低和/或尿白蛋白排泄增加。多项研究表明,这两种标志物中的一种或两种都与中风后的不良功能结局和死亡率显著相关。最近的研究表明,蛋白尿/白蛋白尿比GFR更深入地参与临床结局。尽管目前尚不清楚它们之间关联的机制,但肾小球屏障和/或滤过功能障碍可能与小血管疾病、高凝状态和炎症有关,这可能会影响CKD患者中风后的临床结局。目前缺乏针对CKD患者急性中风最有效管理的证据,因此,目前的中风治疗是根据患者个体背景进行优化的。因此,需要进一步研究以阐明中风的具体特征以及CKD患者中风的管理。

相似文献

1
Stroke features and management in patients with chronic kidney disease.慢性肾脏病患者的卒中特征与管理
Contrib Nephrol. 2013;179:92-9. doi: 10.1159/000346727. Epub 2013 May 3.
2
Cerebrorenal interaction and stroke.脑肾相互作用与中风
Contrib Nephrol. 2013;179:1-6. doi: 10.1159/000346944. Epub 2013 May 3.
3
Antiplatelet therapy for preventing stroke in patients with chronic kidney disease.抗血小板治疗预防慢性肾脏病患者中风
Contrib Nephrol. 2013;179:119-29. doi: 10.1159/000346730. Epub 2013 May 3.
4
Chronic kidney disease and stroke.慢性肾病与中风
Adv Chronic Kidney Dis. 2014 Nov;21(6):500-8. doi: 10.1053/j.ackd.2014.09.001. Epub 2014 Oct 24.
5
Renal impairment reduces the efficacy of thrombolytic therapy in acute ischemic stroke.肾功能损害降低急性缺血性脑卒中溶栓治疗的疗效。
Cerebrovasc Dis. 2013;35(1):45-52. doi: 10.1159/000345071. Epub 2013 Feb 14.
6
Preventing stroke and systemic embolism in renal patients with atrial fibrillation: focus on anticoagulation.预防房颤肾病患者的中风和全身性栓塞:聚焦抗凝治疗。
Contrib Nephrol. 2013;179:81-91. doi: 10.1159/000346726. Epub 2013 May 3.
7
Low glomerular filtration rate increases hemorrhagic transformation in acute ischemic stroke.肾小球滤过率降低会增加急性缺血性脑卒中的出血性转化。
Cerebrovasc Dis. 2013;35(1):53-9. doi: 10.1159/000345087. Epub 2013 Feb 14.
8
Stroke prevention in atrial fibrillation patients with chronic kidney disease.房颤合并慢性肾脏病患者的卒中预防。
Can J Cardiol. 2013 Jul;29(7 Suppl):S71-8. doi: 10.1016/j.cjca.2013.04.005.
9
Renal dysfunction increases the risk of ischemic and hemorrhagic stroke in the general population.肾功能障碍会增加普通人群缺血性和出血性中风的风险。
Ann Med. 2012 Sep;44(6):607-15. doi: 10.3109/07853890.2011.582136. Epub 2011 May 25.
10
In-hospital outcomes with thrombolytic therapy in patients with renal dysfunction presenting with acute ischaemic stroke.肾功能障碍的急性缺血性脑卒中患者溶栓治疗的院内转归。
Nephrol Dial Transplant. 2010 Apr;25(4):1150-7. doi: 10.1093/ndt/gfp619. Epub 2009 Nov 27.

引用本文的文献

1
Serum albumin-to-creatinine ratio as a novel and cost-effective biomarker for silent cerebral infarction: a retrospective cohort study.血清白蛋白与肌酐比值作为无症状性脑梗死的一种新型且经济高效的生物标志物:一项回顾性队列研究
Front Neurol. 2025 Aug 22;16:1633402. doi: 10.3389/fneur.2025.1633402. eCollection 2025.
2
Current status of stroke in hemodialysis patients on a remote island.偏远岛屿上血液透析患者中风的现状。
PLoS One. 2023 Sep 8;18(9):e0288731. doi: 10.1371/journal.pone.0288731. eCollection 2023.
3
Evidence-based medicine among health-care workers in hospitals in Iran: A nationwide survey.
伊朗医院医护人员的循证医学:一项全国性调查。
J Educ Health Promot. 2020 Dec 29;9:365. doi: 10.4103/jehp.jehp_335_20. eCollection 2020.
4
Current Trends Featuring the Bridge Between Stroke and End-Stage Renal Disease: A Review.中风与终末期肾病之间联系的当前趋势:综述
Cureus. 2020 Jul 30;12(7):e9484. doi: 10.7759/cureus.9484.
5
Renal dysfunction and thrombolytic therapy in patients with acute ischemic stroke: a systematic review and meta-analysis.急性缺血性脑卒中患者的肾功能障碍与溶栓治疗:一项系统评价和荟萃分析。
Medicine (Baltimore). 2014 Dec;93(28):e286. doi: 10.1097/MD.0000000000000286.